尿毒症维持性血液透析动静脉内瘘患者发生皮下血肿的相关危险因素<sup>*</sup>

doi:10.3969/j.issn.1671-7171.2025.06.005

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1286 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To explore the related risk factors of subcutaneous hematoma in patients with arteriovenous fistula during uremic maintenance hemodialysis.【Methods】A retrospective analysis was conducted on the clinical data of 120 patients with arteriovenous fistula in uremic maintenance hemodialysis admitted to our hospital from July 2018 to December 2023. The patients were divided into the occurrence group (n=34) and the non-occurrence group (n=86) based on whether subcutaneous hematoma occurred. The clinical data of the patients were collected, and Logistic regression analysis was used to analyze the related risk factors of subcutaneous hematoma in patients with arteriovenous fistula during uremic maintenance hemodialysis.【Results】The proportions of age >65 years old, puncture times ≥3 times, puncture site infection, and compression hemostasis time <30 min after dialysis in the occurrence group were all higher than those in the non-occurrence group, and the differences were statistically significant (P<0.05). The results of Logistic regression analysis showed that age >65 years old, puncture times ≥3 times, puncture site infection, and compression hemostasis time <30 minutes after dialysis were all risk factors for subcutaneous hematoma in patients with arteriovenous fistula during uremic maintenance hemodialysis (P<0.05). 【Conclusion】Puncture site infection, puncture frequency, hemostasis compression time, age, etc. are all related factors affecting the subcutaneous hematoma of arteriovenous fistula in patients undergoing maintenance hemodialysis for uremia. Medical staff should strengthen the prevention and control nursing of puncture site infection, appropriately reduce the puncture frequency, prolong the hemostasis compression time, and enhance the condition monitoring and symptom assessment of elderly patients.

Key words： Uremia Renal Dialysis Arteriovenous Fistula Hematoma Risk Factors

Received: 15 June 2024

PACS:

R692.5

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GAO Chengcheng
	ZHANG Mingming
	LIU Junli
	et al

Cite this article:

GAO Chengcheng,ZHANG Mingming,LIU Junli, et al. Related Risk Factors for Subcutaneous Hematoma in Patients with Arteriovenous Fistula during Uremic Maintenance Hemodialysis[J]. JOURNAL OF CLINICAL RESEARCH, 2025, 42(6): 927-929.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2025.06.005 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2025/V42/I6/927

[1] 杨军,万晨阳,李婷,等. 血清可溶性生长刺激基因表达蛋白2、腱糖蛋白C水平与维持性血液透析患者并发心血管事件的关系[J].中国血液净化,2020,19(6):376-380.
[2] 邬政付,李正胜,谢娟,等. 维持性血液透析病人尿毒症脑病发病危险因素分析[J].安徽医药,2022,26(12):2493-2496.
[3] 伍梦寒,徐艺文,艾霜兰,等. 尿毒症患者血液透析所致导管相关性血流感染的细菌培养和药敏分析[J].中国医学装备,2020,17(4):110-113.
[4] 金其庄, 王玉柱, 叶朝阳, 等.中国血液透析用血管通路专家共识(第2版)[J].中国血液净化, 2019, 18(6): 365-381.
[5] 罗婷. 尿毒症维持性血液透析患者发生动静脉内瘘失功的影响因素及护理对策[J].中外医学研究, 2024, 22(17): 90-93.
[6] 蔡明霞. 中医综合护理干预在预防血液透析动静脉内瘘皮下血肿的应用[J].光明中医, 2022, 37(22): 4173-4175.
[7] 孟令强,董伟,陈秀敏,等. 自我管理能力集束干预对终末期肾病血液透析患者临床依从性和治疗结局的作用[J].中华行为医学与脑科学杂志,2021,30(11):1011-1016.
[8] 李艳艳,单岩,杜理平,等. 希望水平及应对方式对血液透析病人疾病感知的影响[J].护理研究,2019,33(16):2741-2744.
[9] 施晓玲,徐太静,梁炜炜,等. 尿毒症血透患者导管相关性感染影响因素[J].中华医院感染学杂志,2021,31(7):1015-1018.
[10] 卢浩,章磊,张小燕,等. 血清SOST和DHEA-S水平与维持性血液透析患者并发主要心血管不良事件的关系[J].中国中西医结合肾病杂志,2022,23(9):796-798.
[11] MONARDO P, LACQUANITI A, CAMPO S ,et al. Updates on hemodialysis techniques with a common denominator:the personalization of the dialytic therapy[J].Semin Dial,2021,34(3):183-195.
[12] 周悦玲,丁巍,艾红兰,等. 维持性血液透析的终末期肾病患者脑结构性异常及认知功能分析[J].上海交通大学学报(医学版),2020,40(7):962-967.
[13] 刘亚敏,赵培翔,王宇飞,等. 透析导管相关血流感染的危险因素及风险预测模型[J].中华肾脏病杂志,2022,38(1):23.
[14] 叶丽钦,周莹,张海林,等. 社会支持对维持性血液透析老年患者衰弱的影响[J].中华老年医学杂志,2019,38(1):72-75.